LinKinVax (private company)
See something wrong or missing? Let us know
Offices:Paris
Industry:
Health services
Manufacturing
Business model:
B2B
LinKinVax operates as a clinical-stage biotechnology company, developing a protein vaccine platform that accelerates the availability of vaccines based on the work of the VRI (Vaccine Research Institute).
Investors:
we tracked 7 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 12.85m
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Belgium
Netherlands
Austria
Germany
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
Ireland
Italy
Portugal
Spain
United Kingdom